A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2011
10/06/2011	WO2011123858A2 Ccn3 peptides and analogs thereof for therapeutic use
10/06/2011	WO2011122991A1 Indole derivative with antihypertensive effect and method for producing same
10/06/2011	WO2011122899A2 Pharmaceutical composition for inhibiting platelet aggregation or for thrombolysis
10/06/2011	WO2011122805A2 A composition comprising ajoene for preventing or treating a disease caused by overexpression of lxr-alpha
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122468A1 Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes
10/06/2011	WO2011122458A1 Aromatic ring compound containing nitrogen
10/06/2011	WO2011122321A1 Agent for inhibiting physiological activity of heparin-binding protein
10/06/2011	WO2011121354A1 The therapeutic use of tetrathiomolybdate
10/06/2011	WO2011121120A1 ANTAGONISTS OF miRNA-29 EXPRESSION AND THEIR USE IN THE PREVENTION AND TREATMENT OF AORTIC ANEURYSMS
10/06/2011	WO2011120082A1 A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation
10/06/2011	WO2011089234A3 Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
10/06/2011	WO2011063164A3 Sustained release cannabinoid medicaments
10/06/2011	WO2011062906A9 Treatment of atrial fibriallation
10/06/2011	WO2011057251A3 Treatment of heart disease
10/06/2011	WO2011035110A3 Treatment for oxidative stress and/or hypertension
10/06/2011	WO2011034583A3 Inhibition of endosomal toll-like receptor activation
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245340 Screening Method for Identifying Patients at Risk of Adverse Hepatologic Events
10/06/2011	US20110245334 Use of racemates of pinocembrin in preparing medicaments for treating stroke
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245331 Inhibitors of epoxide hydrolases for the treatment of hypertension
10/06/2011	US20110245319 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
10/06/2011	US20110245308 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
10/06/2011	US20110245303 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
10/06/2011	US20110245302 Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
10/06/2011	US20110245301 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
10/06/2011	US20110245297 Use Quaternary Pyridinium Salts as Vasoprotective Agents
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245283 Methods for predicting the response to statins
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245273 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/06/2011	US20110245269 Inhibitors of Advanced Glycation End Products
10/06/2011	US20110245263 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd
10/06/2011	US20110245262 Compounds for treating proliferative disorders
10/06/2011	US20110245253 Method for treating a pulmonary hypertension condition
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245250 Potassium ion channel modulators & uses thereof
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245221 Aryl isoxazole compounds with antitumoural activities
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011	US20110245200 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245179 Composition for Prevention or Treatment of Heart Failure
10/06/2011	US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011	US20110245174 Glp-1 fusion polypeptides
10/06/2011	US20110245173 Long-Acting GLP-1 Derivatives, and Methods of Treating Cardiac Dysfunction
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245169 Protection, restoration and enhancement of erythropoietin responsive cells, tissues and organs
10/06/2011	US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof
10/06/2011	US20110245161 Use of Ghrelin Splice Variant for Treating Hypercholesterolemia and/or High Cholesterol and/or High Cholesterol Complication and/or Lipemia and/or Lipemia Complication and/or Coronary Heart Disease and/or Weight Management and/or Diabetes and/or Hyperglycemia
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245149 Methods to prevent and treat diseases
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244064 composition for the treatment of hypertension
10/06/2011	US20110244060 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244050 Pulsed-release sildenafil composition and method for preparing said composition
10/06/2011	US20110244045 Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
10/06/2011	US20110244033 Tamsulosin pellets for fixed dose combination
10/06/2011	US20110244017 Absorbable Coating For Implantable Device
10/06/2011	US20110244016 Medical implant having a coating composed of or containing at least one active substance
10/06/2011	US20110244014 Implantable medical articles having laminin coatings and methods of use
10/06/2011	US20110244005 Controlled release cgrp delivery composition for cardiovascular and renal indications
10/06/2011	US20110243956 Methods of diagnosing and treating complications of pregnancy
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243952 Compound and method for regulating plasminogen activation and cell migration
10/06/2011	US20110243948 Monoclonal Antibodies Against ANGPTL3
10/06/2011	US20110243943 Treatment using relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243942 Relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243926 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
10/06/2011	US20110243924 Novel methods
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
10/06/2011	US20110243889 Opioid and opioid-like compounds and uses thereof
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110240508 Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
10/06/2011	DE102010013887A1 Fusionsprotein und dessen Verwendungen Fusion protein and uses thereof
10/06/2011	DE102010013587A1 N-(Aminoacyl)-Amino-Ester N- (aminoacyl) -amino-ester
10/06/2011	CA2795164A1 Antagonists of mirna-29 expression and their use in the prevention and treatment of aortic aneurysms
10/06/2011	CA2795064A1 Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes
10/05/2011	EP2371865A2 Antibodies that bind human protein tyrosine phosphatase beta (HPTP-ß) and uses thereof
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371840A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
10/05/2011	EP2371376A1 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/05/2011	EP2371370A1 Antagonists of miRNA-29 expression and their use in the prevention and treatment of aortic aneurysms and atherosclerotic plaque destabilization
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370581A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf

1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1595